Investments abroad · Private equity · Netherlands
Forbion Capital Partners' investments in the United Kingdom
Forbion Capital Partners, based in the Netherlands, has backed 20 startups in the United Kingdom in rounds we track, $3.0B between them, grouped by their main sector.
Forbion Capital Partners's whole portfolioForbion Capital Partners's profile
Biotech
14
Funding by segment
- Biotech$2.2B14
- Agtech$193M2
- Pharma$445M2
- Healthtech$139M2
Where they are based
- United Kingdom20$3.0B
United KingdomFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M4
- $50M to $250M12
- $250M to $1B3
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
16 of 20 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom20
Startups by country, 1 country in all.
Segment by segment
Biotech
14 startups · $2.2B raised
Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
CellCentricCellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.United Kingdom$525M
Achilles TherapeuticsAchilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.United Kingdom$143M- BBioVexTHOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquisUnited Kingdom$133M
Purespring TherapeuticsPurespring Therapeutics is a clinical-stage company based in London, focused on precision nephrology.United Kingdom$128M
Pheon TherapeuticsPheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treatUnited Kingdom$120M- GTGyroscope TherapeuticsGyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.United Kingdom$118M
- MMMemento MedicinesMemento Medicines is a biotech developing bispecific antibody therapies for eye diseases.United Kingdom$93M
Agtech
2 startups · $193M raised
Tropic BiosciencesTropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.United Kingdom$175M
SOLASTA BioSOLASTA® Bio is an agri-biotechnology company based in Glasgow, Scotland, founded in May 2020.United Kingdom$19M
Pharma
2 startups · $445M raised
OMass TherapeuticsOMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule meUnited Kingdom$442M- APArio PharmaArio Pharma is focused on the development of drugs for the treatment of respiratory indications.United Kingdom$3.1M
Healthtech
2 startups · $139M raised
Enterprise TherapeuticsEnterprise Therapeutics Ltd is a UK-based biopharmaceutical company founded in 2014, located at the Sussex Innovation Centre in Brighton.United Kingdom$80M
OxularOxular Limited, based in Oxford, United Kingdom, is a clinical-stage biotechnology company focused on developing innovative drug-dUnited Kingdom$58M
How this map is made. Every startup here has raised money in a round we track that names Forbion Capital Partners as an investor and is based in United Kingdom. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Forbion Capital Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.